Market closed
Protagenic Therapeutics/$PTIX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Protagenic Therapeutics
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Ticker
$PTIX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
2
ISIN
US74365N3017
Website
PTIX Metrics
BasicAdvanced
$1.6M
-
-$15.79
0.29
-
Price and volume
Market cap
$1.6M
Beta
0.29
52-week high
$4.18
52-week low
$2.35
Financial strength
Current ratio
1.997
Quick ratio
1.95
Management effectiveness
Return on assets (TTM)
-113.49%
Return on equity (TTM)
-236.06%
Valuation
Price to book
1.56
Price to tangible book (TTM)
1.56
Price to free cash flow (TTM)
-0.254
Growth
Earnings per share change (TTM)
-2.03%
3-year earnings per share growth (CAGR)
-2.78%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Protagenic Therapeutics stock?
Protagenic Therapeutics (PTIX) has a market cap of $1.6M as of May 14, 2025.
What is the P/E ratio for Protagenic Therapeutics stock?
The price to earnings (P/E) ratio for Protagenic Therapeutics (PTIX) stock is 0 as of May 14, 2025.
Does Protagenic Therapeutics stock pay dividends?
No, Protagenic Therapeutics (PTIX) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Protagenic Therapeutics dividend payment date?
Protagenic Therapeutics (PTIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Protagenic Therapeutics?
Protagenic Therapeutics (PTIX) has a beta rating of 0.29. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.